HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Receivables - Other (2015 - 2026)

HUTCHMED (China)'s (HMDCF) quarterly Receivables - Other came in at $44.0 million in Q2 2026, down 13.11% year-over-year from $50.7 million in Q2 2025, and down 15.01% quarter-over-quarter from $51.8 million in Q4 2025.

Analysis

HUTCHMED (China) (HMDCF) Receivables - Other (2015 - 2026) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Receivables - Other for 12 consecutive years, with $44.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Receivables - Other fell 13.11% year-over-year to $44.0 million in Q2 2026; TTM through Jun 2026 was $44.0 million, a 13.11% decrease from a year earlier, with the FY2025 full-year figure at $51.8 million, changed N/A from the prior year.
  • Receivables - Other was $44.0 million for Q2 2026 at HUTCHMED (China), down from $51.8 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $51.8 million in Q4 2025 and troughed at -$339000.0 in Q4 2023.
  • A 5-year average of $24.7 million and a median of $24.8 million in 2023 frame the typical range for Receivables - Other.
  • The widest YoY moves for Receivables - Other: up 1113.2% in 2023, down 326.0% in 2023.
  • Over 5 years, Receivables - Other stood at $150000.0 in 2022, then plunged by 326.0% to -$339000.0 in 2023, then surged by 8281.71% to $27.7 million in 2024, then surged by 86.75% to $51.8 million in 2025, then fell by 15.01% to $44.0 million in 2026.
  • The last three Receivables - Other figures came in at $44.0 million (Q2 2026), $51.8 million (Q4 2025), and $50.7 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.51 Bn 197.52 Bn 7.24 Bn
2 Gilead Sciences 181.48 Bn 178.30 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.45 Bn 124.60 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.87 Bn 74.88 Bn 3.93 Bn
5 Argenx Se 61.59 Bn 56.41 Bn 1.37 Bn
6 Moderna 54.72 Bn 49.59 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.13 Bn 30.82 Bn 992.69 Mn
8 Biogen 31.29 Bn 30.01 Bn 1.96 Bn
9 Roivant Sciences 30.31 Bn 30.31 Bn 1.16 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 44.02 Mn
Dec 31, 2025 51.80 Mn
Jun 30, 2025 50.66 Mn
Jun 30, 2024 27.74 Mn
Dec 31, 2023 -339,000.00
Jun 30, 2023 21.96 Mn
Dec 31, 2022 150,000.00
Jun 30, 2022 1.81 Mn
Dec 31, 2021 1.51 Mn
Jun 30, 2021 24.23 Mn
Dec 31, 2020 2.96 Mn
Jun 30, 2020 15.25 Mn
Dec 31, 2019 39.67 Mn
Sep 30, 2019 4.19 Mn
Jun 30, 2019 1.79 Mn
Mar 31, 2019 2.19 Mn
Dec 31, 2018 27,000.00
Jun 30, 2018 2.55 Mn
Dec 31, 2017 220,000.00
Jun 30, 2017 2.42 Mn